openPR Logo
Press release

Gout Therapeutics Market on Track for Strong Growth, Estimated to Grow at 11.7% CAGR Through 2029

07-10-2025 07:30 AM CET | Health & Medicine

Press release from: The Business Research Company

Gout Therapeutics Market

Gout Therapeutics Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Gout Therapeutics Market Through 2025?
The market size for gout therapeutics has expanded significantly in recent times. It is projected to rise from $2.88 billion in 2024 to a substantial $3.23 billion by 2025, marking a compound annual growth rate (CAGR) of 12.2%. The historical period of growth is due to factors such as the rising prevalence of gout, changes in lifestyle and diet patterns, the increase in high blood pressure and diabetes incidence, the advancement of xanthine oxidase inhibitors, and initiatives to educate patients.

What's the Projected Size of the Global Gout Therapeutics Market by 2029?
There is a prediction for rapid expansion in the gout therapeutics market size in the coming years. The market is expected to grow to $5.03 billion by 2029, with a compound annual growth rate (CAGR) of 11.7%. The predicted growth during this period can be linked to the increase in healthcare spending, advancements in medication delivery systems, the emergence of new treatment therapies, government-led initiatives for managing chronic diseases, and groups advocating for patient support. Key market trends to watch out for during this forecast period include the development and approval of innovative drugs, personalized treatment plans, utilization of telehealth services in managing gout, and research into therapies that lower urate levels.

View the full report here:
https://www.thebusinessresearchcompany.com/report/gout-therapeutics-global-market-report

Top Growth Drivers in the Gout Therapeutics Industry: What's Accelerating the Market?
The escalating prevalence of gout is anticipated to fuel the expansion of the gout therapeutics market in the future. Gout is an inflammatory arthritis disorder that triggers joint pain and swelling. Therapies for gout aim to treat and alleviate joint discomfort, swelling, and tenderness. Consequently, the escalating rate of gout is predicted to amplify sales in the gout therapeutics market. For example, the Australian Institute of Health and Welfare, a United States government establishment, stated in June 2024 that gout was marked as a fundamental and contributing factor in 573 fatalities in Australia in 2022, translating to 2.2 deaths for every 100,000 individuals. Thus, the escalating prevalence of gout is propelling the expansion of the gout therapeutics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12118&type=smp

What Trends Will Shape the Gout Therapeutics Market Through 2029 and Beyond?
The increasing popularity of product innovation is a noticeable trend in the gout therapeutics market. To maintain their market dominance, key players in the gout therapeutics industry are creating novel treatment approaches. For example, Synlogic Inc., an American pharmaceutical firm, launched SYNB2081, a breakthrough drug for gout therapy in August 2022. The drug, SYNB2081, is a synthetic biotic meant to reduce uric acid levels. This is the second clinical medicine from a research partnership between Synlogic and Ginkgo, an American biotech firm.

What Are the Main Segments in the Gout Therapeutics Market?
The gout therapeutics market covered in this report is segmented -

1) By Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroid, Diuretics
2) By Treatment: Xanthine Oxidase Inhibitor, Uricosuria Medication
3) By Disease Condition: Acute, Chronic
4) By End-Users: Hospitals, Specialty Clinics, Other End Users

Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs, Selective COX-2 Inhibitors
2) By Corticosteroid: Oral Corticosteroids, Injectable Corticosteroids
3) By Diuretics: Thiazide Diuretics, Loop Diuretics

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12118&type=smp

Which Top Companies are Driving Growth in the Gout Therapeutics Market?
Major companies operating in the gout therapeutics market include Sanofi-Aventis, AstraZeneca plc, LG Chem Ltd., GlaxoSmithKline Plc, Takeda Pharmaceuticals Co. Ltd., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Sandoz, Eisai Co. Ltd., Horizon Pharma Plc, Jiangsu HengRui Medicine Co. Ltd., Hikma Pharmaceuticals plc, Swedish Orphan Biovitrum AB, JW Pharmaceutical Corp, Lannett Company Inc, BioCryst Pharmaceuticals Inc., Selecta Biosciences Inc., Rigel Pharmaceuticals Inc., CymaBay Therapeutics Inc., GeneScience Pharmaceuticals Co. Ltd., Shanton Pharma

Which Regions Will Dominate the Gout Therapeutics Market Through 2029?
North America was the largest region in the gout therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gout therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12118

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gout Therapeutics Market on Track for Strong Growth, Estimated to Grow at 11.7% CAGR Through 2029 here

News-ID: 4098638 • Views:

More Releases from The Business Research Company

Major Growth Driver Identified in 2025 Head And Neck Cancer Therapeutics Market: Unveiling The Surge In Head And Neck Cancer Fueling Advancements In Head And Neck Cancer Therapeutics Market
Major Growth Driver Identified in 2025 Head And Neck Cancer Therapeutics Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Head And Neck Cancer Therapeutics Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The size of the market for therapeutics in head and neck cancer has experienced swift growth in the past few years. It is projected to expand from a value of $1.71 billion
Key Factor Supporting Greenhouse Horticulture Market Development in 2025: Surge In Global Food Demand To Drive Market Growth
Key Factor Supporting Greenhouse Horticulture Market Development in 2025: Surge …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Greenhouse Horticulture Market Size By 2025? In recent years, the market size of greenhouse horticulture has seen a swift expansion. The market, which is forecasted to increase from $32.62 billion in 2024 to $36.12 billion in 2025, is predicted to grow at a compound annual
Key Trends Reshaping the Glycol Market: Valvoline Introduces Advanced Glycol-Based Coolant For Enhanced Engine Protection Industry Transformation
Key Trends Reshaping the Glycol Market: Valvoline Introduces Advanced Glycol-Bas …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Glycol Market Size Growth Forecast: What to Expect by 2025? In recent times, the glycol market has seen robust growth. The market value, which was $42.23 billion in 2024, is anticipated to surge to $45.54 billion in 2025, expanding at a compound annual rate (CAGR) of 7.8%. Factors such
Rising Healthcare Expenditure Fuels Growth In The Gastroparesis Market: Transformative Forces Shaping the Gastroparesis Market Landscape in 2025
Rising Healthcare Expenditure Fuels Growth In The Gastroparesis Market: Transfor …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Gastroparesis Industry Market Size Be by 2025? In recent times, the gastroparesis market size has been witnessing a consistent growth. It is projected to advance from $6.84 billion in 2024 to $7.17 billion in 2025, registering a compound annual growth rate (CAGR) of 4.9%. Several factors

All 5 Releases


More Releases for Gout

Global Gout Drugs Market Analysis (2020-2025)
Global Info Research offers a latest published report on Gout Drugs Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Gout Drugs Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/reports/371311/gout-drugs Market
Gout Therapeutics Market Emerging Trends And Forecast By 2025
Global Gout Therapeutics Market: Snapshot The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications. Patients with multiple episodes of severe gout attacks every year or with
Gout Therapeutics Market - Growth Management 2017-2025
Global Gout Therapeutics Market: Snapshot The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications. Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2549 Patients with multiple episodes of
Gout Therapeutics Market Moderately consolidated by 2025
Global Gout Therapeutics Market: Snapshot The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications. Patients with multiple episodes of severe gout attacks every year or with
Gout Therapeutics Market - Future Growth & Forecast 2017-2025
Global Gout Therapeutics Market: Overview Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries. But in the recent times, especially in the U.S., the prevalence of gout has increased to greater extents, which is a reflection of growing population with obesity, smoking habits, and increased intake of alcohol. Increased level of uric acid in the
Gout Therapeutics - Emerging Markets in Developing Countries
Qyresearchreports include new market research report Gout Therapeutics to its huge collection of research reports. The global market for Gout Therapeutics is discussed in detail within a new research study added recently to QYResearchReports.com. The report has been carefully examined both qualitatively and quantitatively and the results are revealed in the research report for the forecast period of 2017 to 2022. In addition to this, the various drivers and restraints, regulatory